Member Sign In
Member Sign Out
Cell & Gene Therapy
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
A*STAR partners with startup to create diabetes cell therapies tailored to Asian patients
March 22, 2023 --
BetaLife has acquired the rights to human induced pluripotent stem cell (iPSC) technology from Singapore’s Agency for Science, Technology, and Research (A*STAR) for use in the treatment of diabetes.
CRISPR/Cas9 mouse model reveals cellular function changes that drive rare disease
March 21, 2023 --
A CRISPR/Cas9 mouse model has shown how mutations that cause a rare disease affect cellular function, shedding light on how to monitor and treat the condition in the process.
Stem cell-loaded plug improves outcomes in hard-to-treat Crohn’s disease patients
March 3, 2023 --
Most Crohn’s disease patients experienced complete clinical healing of perianal fistulas after treatment with a stem cell-loaded plug, according to data published in the journal
Diseases of the Colon & Rectum
At SLAS 2023, companies showcase, launch advanced automation and screening technologies
February 28, 2023 --
At the Society for Laboratory Automation and Screening (SLAS) 2023 International Conference and Exhibition, being held in San Diego from February 25 to March 1, numerous firms have announced that they are showcasing emerging technologies for advanced life science applications.
Beckman Coulter, Sciex collaborate on high-throughput screening workflows
February 27, 2023 --
Life science analytical technologies company Sciex on Monday announced a collaboration with Beckman Coulter Life Sciences to provide comprehensive workflows for high-throughput screening; high-throughput absorption, distribution, metabolism, and excretion (HT-ADME); and synthetic biology studies.
Algorithm predicts success of next-generation CRISPR edits, advancing push to treat genetic diseases
February 16, 2023 --
A machine learning algorithm has predicted the chances of successfully inserting a gene-edited sequence of DNA into a cell using a next-generation CRISPR-Cas9 approach.
Adaptive Biotechnologies Q4 revenues rise 46% on NGS test volumes
February 15, 2023 --
Adaptive Biotechnologies on Tuesday reported fourth-quarter revenue of $55.2 million, up 46% compared with $37.9 million in Q4 2021.
Challenges and remedies for manufacturing cell therapies at scale
February 3, 2023 --
Cell therapies have the potential to cure human diseases rather than just treat the symptoms, and they are potentially life-changing if they can be administered early in a patient’s lifetime.
Aston University partners with longevity biotech to advance lung disease treatment
January 25, 2023 --
Aston University's work on small molecule inhibitors of transglutaminase 2 has spawned a biotech firm focused on treating the chronic lung disease idiopathic pulmonary fibrosis.
Newborn screening for neuromuscular disorder leads to improved outcomes in Australian study
January 18, 2023 --
Newborn screening for spinal muscular atrophy (SMA) improves outcomes by enabling timely access to disease-modifying therapy, a prospective study published in the
Lancet Child & Adolescent Health
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard